Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Makes Splash With Hypertension Disease Awareness Program

This article was originally published in The Pink Sheet Daily

Executive Summary

D.C. press conference to announce “money back guarantee” hypertension treatment program includes HHS Secretary Thompson. Novartis will launch hypertension disease awareness ads in May.

You may also be interested in...



Exforge Money-back Guarantee Leaves DDMAC Complaining

Novartis sales aid touting money-back guarantee on its blood pressure product implies the drug is more effective than competitors with no head-to-head evidence, FDA maintains.

Exforge Money-back Guarantee Leaves DDMAC Complaining

Novartis sales aid touting money-back guarantee on its blood pressure product implies the drug is more effective than competitors with no head-to-head evidence, FDA maintains.

Novartis Ends Hypertension DTC Campaign After FDA Objects To Diovan Link

Novartis has discontinued its unbranded direct-to-consumer advertising campaign on hypertension awareness following objections by FDA

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel